Global Companion Diagnostics (CDx) Development Services Market Research Report 2024

Report ID: 1840147 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Feasibility Studies
        1.2.3 Assay Development
        1.2.4 Analytical Validation
        1.2.5 Clinical Validation
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Infectious Diseases
        1.3.3 Neurological Disorders
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2017-2028)
    2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region
        2.2.1 Companion Diagnostics (CDx) Development Services Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2017-2022)
        2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2023-2028)
    2.3 Companion Diagnostics (CDx) Development Services Market Dynamics
        2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends
        2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers
        2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges
        2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue
        3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2017-2022)
        3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2017-2022)
    3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue
    3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio
        3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2021
    3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served
    3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
    3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type
    4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2017-2022)
    4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application
    5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2017-2022)
    5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
    6.2 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
    6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
    7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
    7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
    8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
    8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
    9.2 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
    9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
    10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
    10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Geneuity-Clinical Research Services
        11.1.1 Geneuity-Clinical Research Services Company Detail
        11.1.2 Geneuity-Clinical Research Services Business Overview
        11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction
        11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.1.5 Geneuity-Clinical Research Services Recent Development
    11.2 Interpace Biosciences
        11.2.1 Interpace Biosciences Company Detail
        11.2.2 Interpace Biosciences Business Overview
        11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction
        11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.2.5 Interpace Biosciences Recent Development
    11.3 Labcorp
        11.3.1 Labcorp Company Detail
        11.3.2 Labcorp Business Overview
        11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction
        11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.3.5 Labcorp Recent Development
    11.4 Quest Diagnostics
        11.4.1 Quest Diagnostics Company Detail
        11.4.2 Quest Diagnostics Business Overview
        11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction
        11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.4.5 Quest Diagnostics Recent Development
    11.5 Q² Solutions
        11.5.1 Q² Solutions Company Detail
        11.5.2 Q² Solutions Business Overview
        11.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Introduction
        11.5.4 Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.5.5 Q² Solutions Recent Development
    11.6 ResearchDx
        11.6.1 ResearchDx Company Detail
        11.6.2 ResearchDx Business Overview
        11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction
        11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.6.5 ResearchDx Recent Development
    11.7 Almac Diagnostic Services
        11.7.1 Almac Diagnostic Services Company Detail
        11.7.2 Almac Diagnostic Services Business Overview
        11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction
        11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.7.5 Almac Diagnostic Services Recent Development
    11.8 Biocartis
        11.8.1 Biocartis Company Detail
        11.8.2 Biocartis Business Overview
        11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction
        11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.8.5 Biocartis Recent Development
    11.9 Cerba Research
        11.9.1 Cerba Research Company Detail
        11.9.2 Cerba Research Business Overview
        11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction
        11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.9.5 Cerba Research Recent Development
    11.10 Eurofins Scientific
        11.10.1 Eurofins Scientific Company Detail
        11.10.2 Eurofins Scientific Business Overview
        11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction
        11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.10.5 Eurofins Scientific Recent Development
    11.11 MLM Medical Labs
        11.11.1 MLM Medical Labs Company Detail
        11.11.2 MLM Medical Labs Business Overview
        11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction
        11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.11.5 MLM Medical Labs Recent Development
    11.12 Qiagen
        11.12.1 Qiagen Company Detail
        11.12.2 Qiagen Business Overview
        11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction
        11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.12.5 Qiagen Recent Development
    11.13 BGI Genomics
        11.13.1 BGI Genomics Company Detail
        11.13.2 BGI Genomics Business Overview
        11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction
        11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.13.5 BGI Genomics Recent Development
    11.14 MEDx Translational Medicine
        11.14.1 MEDx Translational Medicine Company Detail
        11.14.2 MEDx Translational Medicine Business Overview
        11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction
        11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.14.5 MEDx Translational Medicine Recent Development
    11.15 Medical Biological Laboratories (MBL)
        11.15.1 Medical Biological Laboratories (MBL) Company Detail
        11.15.2 Medical Biological Laboratories (MBL) Business Overview
        11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction
        11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.15.5 Medical Biological Laboratories (MBL) Recent Development
    11.16 Novogene
        11.16.1 Novogene Company Detail
        11.16.2 Novogene Business Overview
        11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction
        11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
        11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Feasibility Studies
    Table 3. Key Players of Assay Development
    Table 4. Key Players of Analytical Validation
    Table 5. Key Players of Clinical Validation
    Table 6. Key Players of Others
    Table 7. Global Companion Diagnostics (CDx) Development Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2017-2022)
    Table 11. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2023-2028)
    Table 13. Companion Diagnostics (CDx) Development Services Market Trends
    Table 14. Companion Diagnostics (CDx) Development Services Market Drivers
    Table 15. Companion Diagnostics (CDx) Development Services Market Challenges
    Table 16. Companion Diagnostics (CDx) Development Services Market Restraints
    Table 17. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Companion Diagnostics (CDx) Development Services Market Share by Players (2017-2022)
    Table 19. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2021)
    Table 20. Ranking of Global Top Companion Diagnostics (CDx) Development Services Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Companion Diagnostics (CDx) Development Services Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
    Table 24. Date of Enter into Companion Diagnostics (CDx) Development Services Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2017-2022)
    Table 28. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2023-2028)
    Table 30. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2017-2022)
    Table 32. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2023-2028)
    Table 34. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Geneuity-Clinical Research Services Company Detail
    Table 45. Geneuity-Clinical Research Services Business Overview
    Table 46. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product
    Table 47. Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 48. Geneuity-Clinical Research Services Recent Development
    Table 49. Interpace Biosciences Company Detail
    Table 50. Interpace Biosciences Business Overview
    Table 51. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product
    Table 52. Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 53. Interpace Biosciences Recent Development
    Table 54. Labcorp Company Detail
    Table 55. Labcorp Business Overview
    Table 56. Labcorp Companion Diagnostics (CDx) Development Services Product
    Table 57. Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 58. Labcorp Recent Development
    Table 59. Quest Diagnostics Company Detail
    Table 60. Quest Diagnostics Business Overview
    Table 61. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product
    Table 62. Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 63. Quest Diagnostics Recent Development
    Table 64. Q² Solutions Company Detail
    Table 65. Q² Solutions Business Overview
    Table 66. Q² Solutions Companion Diagnostics (CDx) Development Services Product
    Table 67. Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 68. Q² Solutions Recent Development
    Table 69. ResearchDx Company Detail
    Table 70. ResearchDx Business Overview
    Table 71. ResearchDx Companion Diagnostics (CDx) Development Services Product
    Table 72. ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 73. ResearchDx Recent Development
    Table 74. Almac Diagnostic Services Company Detail
    Table 75. Almac Diagnostic Services Business Overview
    Table 76. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product
    Table 77. Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 78. Almac Diagnostic Services Recent Development
    Table 79. Biocartis Company Detail
    Table 80. Biocartis Business Overview
    Table 81. Biocartis Companion Diagnostics (CDx) Development Services Product
    Table 82. Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 83. Biocartis Recent Development
    Table 84. Cerba Research Company Detail
    Table 85. Cerba Research Business Overview
    Table 86. Cerba Research Companion Diagnostics (CDx) Development Services Product
    Table 87. Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 88. Cerba Research Recent Development
    Table 89. Eurofins Scientific Company Detail
    Table 90. Eurofins Scientific Business Overview
    Table 91. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product
    Table 92. Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 93. Eurofins Scientific Recent Development
    Table 94. MLM Medical Labs Company Detail
    Table 95. MLM Medical Labs Business Overview
    Table 96. MLM Medical Labs Companion Diagnostics (CDx) Development ServicesProduct
    Table 97. MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 98. MLM Medical Labs Recent Development
    Table 99. Qiagen Company Detail
    Table 100. Qiagen Business Overview
    Table 101. Qiagen Companion Diagnostics (CDx) Development ServicesProduct
    Table 102. Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 103. Qiagen Recent Development
    Table 104. BGI Genomics Company Detail
    Table 105. BGI Genomics Business Overview
    Table 106. BGI Genomics Companion Diagnostics (CDx) Development ServicesProduct
    Table 107. BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 108. BGI Genomics Recent Development
    Table 109. MEDx Translational Medicine Company Detail
    Table 110. MEDx Translational Medicine Business Overview
    Table 111. MEDx Translational Medicine Companion Diagnostics (CDx) Development ServicesProduct
    Table 112. MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 113. MEDx Translational Medicine Recent Development
    Table 114. Medical Biological Laboratories (MBL) Company Detail
    Table 115. Medical Biological Laboratories (MBL) Business Overview
    Table 116. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development ServicesProduct
    Table 117. Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 118. Medical Biological Laboratories (MBL) Recent Development
    Table 119. Novogene Company Detail
    Table 120. Novogene Business Overview
    Table 121. Novogene Companion Diagnostics (CDx) Development ServicesProduct
    Table 122. Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
    Table 123. Novogene Recent Development
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostics (CDx) Development Services Market Share by Type: 2021 VS 2028
    Figure 2. Feasibility Studies Features
    Figure 3. Assay Development Features
    Figure 4. Analytical Validation Features
    Figure 5. Clinical Validation Features
    Figure 6. Others Features
    Figure 7. Global Companion Diagnostics (CDx) Development Services Market Share by Application in 2021 & 2028
    Figure 8. Infectious Diseases Case Studies
    Figure 9. Neurological Disorders Case Studies
    Figure 10. Companion Diagnostics (CDx) Development Services Report Years Considered
    Figure 11. Global Companion Diagnostics (CDx) Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Companion Diagnostics (CDx) Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Companion Diagnostics (CDx) Development Services Market Share by Region: 2021 VS 2028
    Figure 14. Global Companion Diagnostics (CDx) Development Services Market Share by Players in 2021
    Figure 15. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2021
    Figure 17. North America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
    Figure 19. United States Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
    Figure 23. Germany Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Share by Region (2017-2028)
    Figure 31. China Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
    Figure 39. Mexico Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
    Figure 43. Turkey Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Geneuity-Clinical Research Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 46. Interpace Biosciences Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 47. Labcorp Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 48. Quest Diagnostics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 49. Q² Solutions Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 50. ResearchDx Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 51. Almac Diagnostic Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 52. Biocartis Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 53. Cerba Research Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 54. Eurofins Scientific Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 55. MLM Medical Labs Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 56. Qiagen Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 57. BGI Genomics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 58. MEDx Translational Medicine Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 59. Medical Biological Laboratories (MBL) Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 60. Novogene Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Frequently Asked Questions
Companion Diagnostics (CDx) Development Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Companion Diagnostics (CDx) Development Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Companion Diagnostics (CDx) Development Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports